PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis

Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif., Sept. 27, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of a new computational analysis…